biopharmaceutical - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

TiGenix announces approval of trade name for lead development candidate Cx601 in Europe

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-...

20 November 2017 News allogeneic | anti-inflammatory

Continue Reading →

News

New BEAM Alliance Position Paper calls out worldwide stakeholders to support SME-driven innovation and revive the product pipeline fighting antimicrobial resistance

In 2017, the collective fight to combat antimicrobial resistance (AMR) has experienced a new upswing. Following the eye-opening report of British economist Lord Jim ...

17 November 2017 News antibiotic | antimicrobial

Continue Reading →

News

Vetter expands its footprint in Asia Pacific region

Vetter, one of the global leaders in prefilled drug-delivery systems, today announced the official opening of a new branch office in South Korea. The new office in S...

9 November 2017 News biologics | biopharmaceutical

Continue Reading →

Clinical Research v4i3

Allergy and Biopharmaceutical Therapy, Part 1: Background and Current Treatment Regimens

A fairly good knowledge base concerning various steps in allergic reactions now exists, but despite this knowledge the prevalence of allergic diseases is still i...

28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 allergy | biopharmaceutical

Continue Reading →

Manufacturing v4i3

Answering Pharma’s Need for Outsourcing to Process ‘Intensification’ Technology for the Future of Biopharmaceutical Production

The chemical and pharmaceutical industry will face challenges in the future related to manufacturing costs and lowering environmental impact. Chemical and biopha...

28 September 2012 Manufacturing v4i3 | Volume 4 Issue 3 biopharmaceutical | manufacturing

Continue Reading →

Future-ready ADCs – advanced vial solutions for superior stability and performance

Alternative Drug Delivery Routes: Opportunities, Challenges, and How to Overcome Them

Bridging the gap between R&D and GMP

Current Edition

Current Edition

Subsection - CDMO

Subsection - Injectables

Subsection - Neurodegenerative Diseases

Subsection - Nasal & Pulmonary

TiGenix announces approval of trade name for lead development candidate Cx601 in Europe

New BEAM Alliance Position Paper calls out worldwide stakeholders to support SME-driven innovation and revive the product pipeline fighting antimicrobial resistance

Vetter expands its footprint in Asia Pacific region

Allergy and Biopharmaceutical Therapy, Part 1: Background and Current Treatment Regimens

Answering Pharma’s Need for Outsourcing to Process ‘Intensification’ Technology for the Future of Biopharmaceutical Production

International Pharmaceutical Industry